Luque AE - Search Results

1

Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota.

Mitchell C, Hitti J, Paul K, Agnew K, Cohn SE, Luque AE, Coombs R. Mitchell C, et al. Among authors: luque ae. AIDS Res Hum Retroviruses. 2011 Jan;27(1):35-9. doi: 10.1089/aid.2010.0129. Epub 2010 Oct 7. AIDS Res Hum Retroviruses. 2011. PMID: 20929397 Free PMC article.

2

Bacterial vaginosis, not HIV, is primarily responsible for increased vaginal concentrations of proinflammatory cytokines.

Mitchell CM, Balkus J, Agnew KJ, Cohn S, Luque A, Lawler R, Coombs RW, Hitti JE. Mitchell CM, et al. AIDS Res Hum Retroviruses. 2008 May;24(5):667-71. doi: 10.1089/aid.2007.0268. AIDS Res Hum Retroviruses. 2008. PMID: 18462081 Free PMC article.

3

Detection of hydrogen peroxide-producing Lactobacillus species in the vagina: a comparison of culture and quantitative PCR among HIV-1 seropositive women.

Balkus JE, Mitchell C, Agnew K, Liu C, Fiedler T, Cohn SE, Luque A, Coombs R, Fredricks DN, Hitti J. Balkus JE, et al. BMC Infect Dis. 2012 Aug 13;12:188. doi: 10.1186/1471-2334-12-188. BMC Infect Dis. 2012. PMID: 22889380 Free PMC article.

4

Interaction between lactobacilli, bacterial vaginosis-associated bacteria, and HIV Type 1 RNA and DNA Genital shedding in U.S. and Kenyan women.

Mitchell C, Balkus JE, Fredricks D, Liu C, McKernan-Mullin J, Frenkel LM, Mwachari C, Luque A, Cohn SE, Cohen CR, Coombs R, Hitti J. Mitchell C, et al. AIDS Res Hum Retroviruses. 2013 Jan;29(1):13-9. doi: 10.1089/AID.2012.0187. Epub 2012 Nov 5. AIDS Res Hum Retroviruses. 2013. PMID: 23020644 Free PMC article.

5

Associations between genital tract infections, genital tract inflammation, and cervical cytobrush HIV-1 DNA in US versus Kenyan women.

Mitchell C, Balkus JE, McKernan-Mullin J, Cohn SE, Luque AE, Mwachari C, Cohen CR, Coombs R, Frenkel LM, Hitti J. Mitchell C, et al. Among authors: luque ae. J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):143-8. doi: 10.1097/QAI.0b013e318274577d. J Acquir Immune Defic Syndr. 2013. PMID: 23018377 Free PMC article.

6

Prevalence of human papillomavirus genotypes in HIV-1-infected women in Seattle, USA and Nairobi, Kenya: results from the Women's HIV Interdisciplinary Network (WHIN).

Luque AE, Hitti J, Mwachari C, Lane C, Messing S, Cohn SE, Adler D, Rose R, Coombs R. Luque AE, et al. Int J Infect Dis. 2010 Sep;14(9):e810-4. doi: 10.1016/j.ijid.2010.03.016. Epub 2010 Jul 22. Int J Infect Dis. 2010. PMID: 20655263 Free PMC article.

7

HIV-1 RNA levels and antiretroviral drug resistance in blood and non-blood compartments from HIV-1-infected men and women enrolled in AIDS clinical trials group study A5077.

Kantor R, Bettendorf D, Bosch RJ, Mann M, Katzenstein D, Cu-Uvin S, D'Aquila R, Frenkel L, Fiscus S, Coombs R; ACTG A5077 Study Team. Kantor R, et al. PLoS One. 2014 Apr 3;9(4):e93537. doi: 10.1371/journal.pone.0093537. eCollection 2014. PLoS One. 2014. PMID: 24699474 Free PMC article. Clinical Trial.

8

Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.

Weinberg A, Park JG, Bosch R, Cho A, Livingston E, Aweeka F, Cramer Y, Watts DH, Luque AE, Cohn SE. Weinberg A, et al. Among authors: luque ae. J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):137-45. doi: 10.1097/QAI.0000000000000850. J Acquir Immune Defic Syndr. 2016. PMID: 26413850 Free PMC article. Clinical Trial.

9

Depot medroxyprogesterone acetate in combination with a twice-daily lopinavir-ritonavir-based regimen in HIV-infected women showed effective contraception and a lack of clinically significant interactions, with good safety and tolerability: results of the ACTG 5283 study.

Luque AE, Cohn SE, Park JG, Cramer Y, Weinberg A, Livingston E, Klingman KL, Aweeka F, Watts DH. Luque AE, et al. Antimicrob Agents Chemother. 2015 Apr;59(4):2094-101. doi: 10.1128/AAC.04701-14. Epub 2015 Jan 26. Antimicrob Agents Chemother. 2015. PMID: 25624326 Free PMC article. Clinical Trial.

10

No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy.

Gandhi RT, Coombs RW, Chan ES, Bosch RJ, Zheng L, Margolis DM, Read S, Kallungal B, Chang M, Goecker EA, Wiegand A, Kearney M, Jacobson JM, D'Aquila R, Lederman MM, Mellors JW, Eron JJ; AIDS Clinical Trials Group (ACTG) A5244 Team. Gandhi RT, et al. J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):229-35. doi: 10.1097/QAI.0b013e31823fd1f2. J Acquir Immune Defic Syndr. 2012. PMID: 22083073 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters